Baillie Gifford & Co’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $7.38K | Sell |
|
|||||
|
2024
Q4 | $13.9M | Buy |
|
|||||
|
2024
Q3 | $13.5M | Buy |
|
|||||
|
2024
Q2 | $14M | Buy |
|
|||||
|
2024
Q1 | $18.3M | Sell |
|
|||||
|
2023
Q4 | $16.6M | Sell |
|
|||||
|
2023
Q3 | $15.6M | Sell |
|
|||||
|
2023
Q2 | $17.9M | Sell |
|
|||||
|
2023
Q1 | $17.3M | Buy |
|
|||||
|
2022
Q4 | $15.6M | Sell |
|
|||||
|
2022
Q3 | $14.2M | Buy |
|
|||||
|
2022
Q2 | $3.38M | Buy |
|